- $1.16m
- $886.83m
- $945.95m
Annual income statement for 2U, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 575 | 775 | 946 | 963 | 946 |
Cost of Revenue | |||||
Gross Profit | 297 | 385 | 497 | 495 | 512 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 821 | 965 | 1,114 | 1,221 | 1,188 |
Operating Profit | -247 | -191 | -169 | -258 | -243 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -255 | -218 | -196 | -323 | -316 |
Provision for Income Taxes | |||||
Net Income After Taxes | -235 | -216 | -195 | -322 | -318 |
Net Income Before Extraordinary Items | |||||
Net Income | -235 | -216 | -195 | -322 | -318 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -235 | -216 | -195 | -322 | -318 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -86.3 | -98.1 | -70.8 | -80.9 | -55.5 |